VWF is a plasma protein that binds platelets to an injured vascular wall during thrombosis. When exposed to the shear forces found in flowing blood, VWF molecules undergo lateral self-association that results in a meshwork of VWF fibers. Fiber formation has been shown to involve thiol/disulfide exchange between VWF molecules. A C-terminal fragment of VWF was expressed in mammalian cells and examined for unpaired cysteine thiols using tandem mass spectrometry (MS). The VWF C2 domain Cys2431-Cys2453 disulfide bond was shown to be reduced in approximately 75% of the molecules. Fragments containing all 3 C domains or just the C2 domain formed monomers, dimers, and higher-order oligomers when expressed in mammalian cells. Mutagenesis studies showed that both the Cys2431-Cys2453 and nearby Cys2451-Cys2468 disulfide bonds were involved in oligomer formation. Our present findings imply that lateral VWF dimers form when a Cys2431 thiolate anion attacks the Cys2431 sulfur atom of the Cys2431-Cys2453 disulfide bond of another VWF molecule, whereas the Cys2451-Cys2468 disulfide/dithiol mediates formation of trimers and higher-order oligomers. These observations provide the basis for exploring defects in lateral VWF association in patients with unexplained hemorrhage or thrombosis. (Blood. 2011;118(19): 5312-5318)
IntroductionVWF is a large, multimeric glycoprotein responsible for chaperoning the blood coagulation cofactor factor VIII and tethering platelets to the site of vascular endothelial injury. 1 It is synthesized by vascular endothelial cells and megakaryocytes and circulates as a series of multimers containing variable numbers of 500-kDa dimeric units. Circulating multimers range between 500 and 20 000 kDa in size, and although any size multimer is able to chaperone factor VIII, 2 it is the only the largest sizes that are able to effectively tether platelets. Each subunit contains binding sites for collagen and for platelet glycoproteins Ib and ␣IIb3. 1 Multimer size is regulated in the circulation. An excess of high-molecular-weight multimers can cause unwanted thrombosis and is associated with thrombotic thrombocytopenic purpura, 3 whereas a paucity of large multimers is associated with the bleeding disorder VWD. 1 Under normal conditions, the size of VWF multimers is controlled by ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type-1 motifs) proteolysis of the Tyr1605-Met1606 peptide bond in the A2 domain. 4 The tertiary and quaternary structure of VWF is influenced by the shear forces typically found in flowing blood. VWF undergoes a shear-dependent conformational change, 5 and individual molecules can self-associate under both static 6 and shear conditions. 7-9 VWF reversibly transitions from a loosely coiled ball to an elongated structure in response to shear. 5,10,11 Self-association of VWF has been reported in different systems. Soluble VWF perfused over a VWF-coated surface undergoes "homotypic" self-association that facilitates platelet adhesion. 9 In addition, VWF self-associates into ...